AI assistant
Cardlytics, Inc. — Director's Dealing 2019
Nov 15, 2019
33956_dirs_2019-11-15_8f937d39-5d1c-4eb5-86f0-838661d16749.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-11-13
Reporting Person: Evans David Thomas (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-13 | Common Stock | S | 5000 | $55 | Disposed | 36565 | Direct |
| 2019-11-13 | Common Stock | S | 5000 | $50 | Disposed | 31565 | Direct |
| 2019-11-13 | Common Stock | S | 2000 | $47.65 | Disposed | 29565 | Direct |
| 2019-11-15 | Common Stock | S | 3000 | $57.12 | Disposed | 26565 | Direct |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2019.
F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.